Video

Taking a Closer Look at PCSK9

Author(s):

One of the hot topics at the American College of Cardiology's annual meeting in San Diego was a new class of drugs being developed that could revolutionize the field of cardiac care.

One of the hot topics at the American College of Cardiology's annual meeting in San Diego was a new class of drugs being developed that could revolutionize the field of cardiac care.

Jennifer Robinson, MD, MPH, from the University of Iowa discussed this latest development while presenting two paper on the topic at the event.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.